nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study
|
Serafino-Agrusa, Laura |
|
2016 |
37 |
C |
p. 89-94 6 p. |
artikel |
2 |
Bronchodilator effects, pharmacokinetics and safety of PSX1002-GB, a novel glycopyrronium bromide formulation, in COPD patients; a randomised crossover study
|
Singh, Dave |
|
2016 |
37 |
C |
p. 9-14 6 p. |
artikel |
3 |
Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy
|
Hozawa, Soichiro |
|
2016 |
37 |
C |
p. 15-23 9 p. |
artikel |
4 |
Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler
|
Hojo, Masayuki |
|
2016 |
37 |
C |
p. 43-48 6 p. |
artikel |
5 |
Editorial Board
|
|
|
2016 |
37 |
C |
p. IFC- 1 p. |
artikel |
6 |
Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study
|
Esposito, Antonietta |
|
2016 |
37 |
C |
p. 85-88 4 p. |
artikel |
7 |
Effect of rituximab on pulmonary function in patients with rheumatoid arthritis
|
Franzen, Daniel |
|
2016 |
37 |
C |
p. 24-29 6 p. |
artikel |
8 |
Effects of low- versus high-dose fluticasone propionate/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial
|
Kanniess, Frank |
|
2016 |
37 |
C |
p. 65-72 8 p. |
artikel |
9 |
In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems
|
Mashat, M. |
|
2016 |
37 |
C |
p. 37-42 6 p. |
artikel |
10 |
Mitochondrial N-formyl peptides cause airway contraction and lung neutrophil infiltration via formyl peptide receptor activation
|
Wenceslau, Camilla Ferreira |
|
2016 |
37 |
C |
p. 49-56 8 p. |
artikel |
11 |
Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects
|
Vaidya, Soniya S. |
|
2016 |
37 |
C |
p. 30-36 7 p. |
artikel |
12 |
Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study
|
Ohbayashi, Hiroyuki |
|
2016 |
37 |
C |
p. 73-80 8 p. |
artikel |
13 |
RIP140 down-regulation alleviates acute lung injury via the inhibition of LPS-induced PPARγ promoter methylation
|
Lei, Chuanjiang |
|
2016 |
37 |
C |
p. 57-64 8 p. |
artikel |
14 |
The role of tyrosine kinase inhibitor “Lapatinib” in pulmonary hypertension
|
Alkhatib, Yaser |
|
2016 |
37 |
C |
p. 81-84 4 p. |
artikel |
15 |
Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease
|
Jiang, Zhilong |
|
2016 |
37 |
C |
p. 1-8 8 p. |
artikel |